These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38219833)

  • 1. Comparison of different regimens of short-term antibiotic prophylaxis in transrectal prostate biopsy.
    Krsakova E; Cermak A; Fedorko M
    J Hosp Infect; 2024 Mar; 145():83-87. PubMed ID: 38219833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Augmented Antimicrobial Prophylaxis and Rectal Swab Culture-guided Targeted Prophylaxis on the Risk of Sepsis Following Transrectal Prostate Biopsy.
    Hadjipavlou M; Eragat M; Kenny C; Pantelidou M; Mulhem W; Wood C; Dall'Antonia M; Hammadeh MY
    Eur Urol Focus; 2020 Jan; 6(1):95-101. PubMed ID: 31928632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
    Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
    Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: A prospective randomized study.
    Van Besien J; Uvin P; Weyne E; Van Praet C; Merckx L; De Graeve N; Van Renterghem K; Cartuyvels R; Van den Abeele AM
    Int J Urol; 2019 Mar; 26(3):391-397. PubMed ID: 30588680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of amikacin with fosfomycin as an add-on to ciprofloxacin for antibiotic prophylaxis in transrectal prostate biopsy: A single-center retrospective study.
    Yu SH; Jung SI; Ryu JW; Kim MS; Chung HS; Hwang EC; Kwon DD
    Investig Clin Urol; 2022 Nov; 63(6):663-670. PubMed ID: 36347556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
    Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
    World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
    Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
    Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
    Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
    J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal Culture-Based Versus Empirical Antibiotic Prophylaxis to Prevent Infectious Complications in Men Undergoing Transrectal Prostate Biopsy: A Randomized, Nonblinded Multicenter Trial.
    Tops SCM; Kolwijck E; Koldewijn EL; Somford DM; Delaere FJM; van Leeuwen MA; Breeuwsma AJ; de Vocht TF; Broos HJHP; Schipper RA; Steffens MG; Teerenstra S; Wegdam-Blans MCA; de Brauwer E; van den Bijllaardt W; Leenders ACAP; Sedelaar JPM; Wertheim HFL
    Clin Infect Dis; 2023 Apr; 76(7):1188-1196. PubMed ID: 36419331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment to: "Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin".
    Jiménez-Pacheco A
    Actas Urol Esp; 2015 Apr; 39(3):137-8. PubMed ID: 25443521
    [No Abstract]   [Full Text] [Related]  

  • 15. [Optimization of prevention of infectious complications during prostate biopsy].
    Kolontarev K B; Stroganov R V; Pushkar D Y
    Urologiia; 2023 Dec; (6):128-132. PubMed ID: 38156696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
    Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
    J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of a prospective, randomized trial with respect to risk factors.
    Kisa E; Altug MU; Gurbuz OA; Ozdemir H
    Int Braz J Urol; 2017; 43(6):1068-1074. PubMed ID: 28727372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate.
    Siyez E
    Medicine (Baltimore); 2021 Oct; 100(41):e27539. PubMed ID: 34731153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy.
    Taylor S; Margolick J; Abughosh Z; Goldenberg SL; Lange D; Bowie WR; Bell R; Roscoe D; Machan L; Black P
    BJU Int; 2013 May; 111(6):946-53. PubMed ID: 23464844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Two Fosfomycin Regimens as Antimicrobial Prophylaxis for Transrectal Prostate Biopsy: A Randomised Study.
    D'Elia C; Mian C; Hanspeter E; Ladurner C; Palermo SM; Pycha S; Saleh O; Cai T; Spoladore G; Kafka M; Pycha A; Trenti E
    Urol Int; 2019; 103(4):433-438. PubMed ID: 31614361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.